{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T10:11:08Z","timestamp":1769076668735,"version":"3.49.0"},"reference-count":32,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.3892\/or.2012.1625","type":"journal-article","created":{"date-parts":[[2012,1,11]],"date-time":"2012-01-11T08:47:32Z","timestamp":1326271652000},"page":"1238-1244","source":"Crossref","is-referenced-by-count":66,"title":["Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer"],"prefix":"10.3892","volume":"27","author":[{"given":"DONG-XIAN","family":"PENG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MIN","family":"LUO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LI-WEN","family":"QIU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUAN-LI","family":"HE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XUE-FENG","family":"WANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2012,1,11]]},"reference":[{"key":"key20180107213743_b1-or-27-04-1238","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 5","key":"key20180107213743_b2-or-27-04-1238","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1634\/theoncologist.7-suppl_5-20","article-title":"Relapsed ovarian cancer: challenges and management strategies for a chronic disease","volume":"7","author":"Armstrong","year":"2002","journal-title":"Oncologist"},{"key":"key20180107213743_b3-or-27-04-1238","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"key20180107213743_b4-or-27-04-1238","first-page":"747","article-title":"Biological functions of microRNAs","volume":"36","author":"Huang","year":"2010","journal-title":"Bioorg Khim"},{"key":"key20180107213743_b5-or-27-04-1238","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s13105-010-0050-6","article-title":"Biological functions of microRNAs: a review","volume":"67","author":"Huang","year":"2011","journal-title":"J Physiol Biochem"},{"key":"key20180107213743_b6-or-27-04-1238","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2165\/00063030-200721020-00004","article-title":"MicroRNAs in the search for understanding human diseases","volume":"21","author":"Perera","year":"2007","journal-title":"BioDrugs"},{"key":"key20180107213743_b7-or-27-04-1238","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers","volume":"6","author":"Calin","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"key20180107213743_b8-or-27-04-1238","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1677\/ERC-09-0203","article-title":"MicroRNAs in ovarian carcinomas","volume":"17","author":"Dahiya","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"key20180107213743_b9-or-27-04-1238","doi-asserted-by":"crossref","first-page":"9136","DOI":"10.1073\/pnas.0508889103","article-title":"microRNAs exhibit high frequency genomic alterations in human cancer","volume":"103","author":"Zhang","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107213743_b10-or-27-04-1238","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1158\/0008-5472.CAN-07-2488","article-title":"MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN","volume":"68","author":"Yang","year":"2008","journal-title":"Cancer Res"},{"key":"key20180107213743_b11-or-27-04-1238","doi-asserted-by":"crossref","first-page":"e5311","DOI":"10.1371\/journal.pone.0005311","article-title":"Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries","volume":"4","author":"Wyman","year":"2009","journal-title":"PLoS One"},{"key":"key20180107213743_b12-or-27-04-1238","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1038\/onc.2010.642","article-title":"MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14)","volume":"30","author":"Wang","year":"2011","journal-title":"Oncogene"},{"key":"key20180107213743_b13-or-27-04-1238","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1582-4934.2009.00964.x","article-title":"Identification of microRNA profiles in docetaxel-resistant human non-small cell lung carcinoma cells (SPC-A1)","volume":"14","author":"Rui","year":"2010","journal-title":"J Cell Mol Med"},{"key":"key20180107213743_b14-or-27-04-1238","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1002\/jcp.22662","article-title":"New players in ovarian cancer","volume":"226","author":"Bovicelli","year":"2011","journal-title":"J Cell Physiol"},{"key":"key20180107213743_b15-or-27-04-1238","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1111\/j.1582-4934.2010.01058.x","article-title":"The role of microRNAs in ovarian cancer initiation and progression","volume":"14","author":"Li","year":"2010","journal-title":"J Cell Mol Med"},{"key":"key20180107213743_b16-or-27-04-1238","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejca.2010.11.005","article-title":"MicroRNA regulation of core apoptosis pathways in cancer","volume":"47","author":"Lima","year":"2011","journal-title":"Eur J Cancer"},{"key":"key20180107213743_b17-or-27-04-1238","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1158\/0008-5472.CAN-10-1346","article-title":"MicroRNAs and metastasis: little RNAs go a long way","volume":"70","author":"Dykxhoorn","year":"2010","journal-title":"Cancer Res"},{"key":"key20180107213743_b18-or-27-04-1238","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.biocel.2010.01.014","article-title":"MicroRNAs in ovarian cancer biology and therapy resistance","volume":"42","author":"van Jaarsveld","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"key20180107213743_b19-or-27-04-1238","doi-asserted-by":"crossref","first-page":"10117","DOI":"10.1158\/0008-5472.CAN-07-2544","article-title":"Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis","volume":"67","author":"Lu","year":"2007","journal-title":"Cancer Res"},{"key":"key20180107213743_b20-or-27-04-1238","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ygyno.2011.04.033","article-title":"MicroRNA let-7a: a potential marker for selection of paclitaxel in ovarian cancer management","volume":"122","author":"Lu","year":"2011","journal-title":"Gynecol Oncol"},{"key":"key20180107213743_b21-or-27-04-1238","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3892\/ijmm_00000530","article-title":"MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein","volume":"26","author":"Lou","year":"2010","journal-title":"Int J Mol Med"},{"key":"key20180107213743_b22-or-27-04-1238","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1158\/0008-5472.CAN-07-2488","article-title":"MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN","volume":"68","author":"Yang","year":"2008","journal-title":"Cancer Res"},{"key":"key20180107213743_b23-or-27-04-1238","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ygyno.2008.08.017","article-title":"Role of microRNAs in drug-resistant ovarian cancer cells","volume":"2111","author":"Sorrentino","year":"2008","journal-title":"Gynecol Oncol"},{"key":"key20180107213743_b24-or-27-04-1238","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ygyno.2010.06.004","article-title":"MiR-27a modulates MDR1\/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells","volume":"119","author":"Li","year":"2010","journal-title":"Gynecol Oncol"},{"key":"key20180107213743_b25-or-27-04-1238","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1002\/ijc.24880","article-title":"Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer","volume":"126","author":"Shi","year":"2010","journal-title":"Int J Cancer"},{"key":"key20180107213743_b26-or-27-04-1238","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.juro.2010.10.035","article-title":"MicroRNA-100 expression is independently related to biochemical recurrence of prostate cancer","volume":"185","author":"Leite","year":"2011","journal-title":"J Urol"},{"key":"key20180107213743_b27-or-27-04-1238","article-title":"MiR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia","author":"Zheng","year":"2011","journal-title":"Oncogene"},{"key":"key20180107213743_b28-or-27-04-1238","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ceb.2008.10.005","article-title":"Polo-like kinase 1 reaches beyond mitosis-cytokinesis, DNA damage response, and development","volume":"20","author":"Takaki","year":"2008","journal-title":"Curr Opin Cell Biol"},{"key":"key20180107213743_b29-or-27-04-1238","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/sj.bjc.6601610","article-title":"Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma","volume":"90","author":"Weichert","year":"2004","journal-title":"Br J Cancer"},{"key":"key20180107213743_b30-or-27-04-1238","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1158\/1078-0432.CCR-09-1380","article-title":"Targeting Polo-like kinase in cancer therapy","volume":"16","author":"Degenhardt","year":"2010","journal-title":"Clin Cancer Res"},{"key":"key20180107213743_b31-or-27-04-1238","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrc1841","article-title":"Targeting polo-like kinase 1 for cancer therapy","volume":"6","author":"Strebhardt","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"key20180107213743_b32-or-27-04-1238","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s10495-006-9421-4","article-title":"Influence of chk1 and plk1 silencing on radiation- or cisplatin-induced cytotoxicity in human malignant cells","volume":"11","author":"Gao","year":"2006","journal-title":"Apoptosis"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2012.1625\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T15:04:51Z","timestamp":1713366291000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2012.1625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,11]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,1,11]]},"published-print":{"date-parts":[[2012,4]]}},"alternative-id":["10.3892\/or.2012.1625"],"URL":"https:\/\/doi.org\/10.3892\/or.2012.1625","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,11]]}}}